Trial intelligence / Profile preview

CO2 to Prevent Cerebral Hypoxia in Bariatric Surgery

NCT03338907Phase 2Completed

Sponsor
University of Zurich
Start
Jan 2018
Primary completion
Oct 2018
Modality
Inhalation Devices
Countries
1
01

Overview

A Phase 2 trial of Carbon dioxide in Cerebral Hypoxia, sponsored by University of Zurich. Started Jan 2018; status: completed.

02

Drugs

Carbon dioxide
03

Conditions

Cerebral Hypoxia

Beyond the preview

Go deeper on NCT03338907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03338907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call